论文信息 - Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents? - 字舞流文

Response to First Cycle Is the Major Predictor of Long-Term Response to Lenalidomide and Dexamethasone Therapy in Relapsed and Refractory Multiple Myeloma: Can We Spare Patients the Toxicity and Costs of Additional Agents?

A. Oriol | J. Ribera | C. Motlló | M. Morgades | C. Maluquer | S. Gassiot | L. Abril | G. Ibarra | Y. González | V. Clapés | Cristina Motlló | Y. González